Clinical Trial

PREVENT HPV -Related Cancers Trial

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 5, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States. The proposed study will assess the effectiveness of a clinic-based behavioral outreach intervention to increase HPV vaccination rates at community clinics in rural counties. The intervention consists of communication and engagement strategies delivered within routine care settings and is designed to pose no more than minimal risk to participants.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-02-01 -> 2026-07-01 2026-05-29
minor Completion pushed: 2026-07-01 -> 2027-02-01 2026-05-29
critical Phase changed: not applicable -> Phase 3 2026-04-08
Trial Details
NCT Number NCT07217145
Lead Sponsor University of Utah
Collaborators: Kaiser Permanente, University of Arizona, Sea Mar Community Health Centers, National Cancer Institute (NCI)
Conditions HPV Vaccination, Uptake Vaccination, Series Completion
Enrollment 1,455 participants
Start Date 2025-10-06
Primary Completion 2026-07-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-05